Manufacturer

Fagron Compounding Services

10 recalls in our database name Fagron Compounding Services as the manufacturing or recalling firm.

What the numbers show

Total: 10
Critical: 0
Severe: 0
Most recent: 2026-04-15

Of the 10 recalls from Fagron Compounding Services we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 0 (0%) are Severe.

About this listing

The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.

Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.

1–10 of 10

HighFDA (Drugs)·D-0438-2026·2026-04-15
Fagron norepinephrine infusion bags recalled over sterility and detaching port part
Fagron is recalling norepinephrine bitartrate 16 mg in 250 mL sodium chloride bags for lack of assurance of sterility and because a blue break-off part could detach from the administration port.
Product
norepinephrine Bitartrate,16mg per 250mL 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5026-02
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0442-2026·2026-04-15
Fagron vancomycin infusion bags recalled over sterility and detaching port part
Fagron Sterile Services is recalling Vancomycin HCl 1 gram in 250 mL sodium chloride bags for lack of assurance of sterility and because a blue break-off part could detach from the administration port.
Product
Vancomycin HCL, 1 gram added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5082-01
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0441-2026·2026-04-15
Fagron vancomycin 1.5 gram bags recalled over sterility and detaching port part
Fagron is recalling Vancomycin HCl 1.5 grams in 250 mL sodium chloride bags for lack of assurance of sterility and because a blue break-off part could detach from the administration port.
Product
Vancomycin HCI, 1.5 grams added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5085-01
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0439-2026·2026-04-15
Fagron norepinephrine 32 mg bags recalled over sterility and port part
Fagron is recalling norepinephrine bitartrate 32 mg in 250 mL sodium chloride bags for lack of assurance of sterility and because a blue break-off part could detach from the administration port.
Product
norepinephrine Bitartrate, 32mg per 250mL 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5027-02
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0440-2026·2026-04-15
Fagron vancomycin 1.25 gram bags recalled over sterility and detaching port part
Fagron is recalling Vancomycin HCl 1.25 grams in 250 mL sodium chloride bags for lack of assurance of sterility and because a blue break-off part could detach from the administration port.
Product
Vancomycin HCI, 1.25 grams added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5083-01
Category
Drug
Distribution
Distributed nationwide
ModerateFDA (Drugs)·D-0221-2026·2025-12-17
Compounded ophthalmic syringes recalled over an incorrect product formulation
Fagron Compounding Services is recalling 2,980 syringes of a compounded topical ophthalmic solution over an incorrect product formulation.
Product
Tropicamide 1%/Cyclopentolate 1%/Phenylephrine 2.5%/Ketorolac 0.5% Topical Ophthalmic Solution, 0.5mL Single-Use Syringe, For Topical Ophthalmic Use Only. Not for IV Use. Fagron Sterile Services, 8710 E 34th St N, Wichita, KS 67226. NDC: 71266-8240-01
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0646-2025·2025-09-24
Compounded bevacizumab syringes recalled for lack of assurance of sterility
Fagron Sterile Services bevacizumab (Avastin) Injection, 1.25 mg/0.05 mL single-dose syringes, is recalled nationwide for lack of assurance of sterility. 109,320 syringes are affected.
Product
bevacizumab (Avastin) Injection, 1.25mg/0.05mL (0.12 mL Fill), Sterile Single-Dose Syringe, Fagron Sterile Services, 8710 E 34th St N. Wichita, KS 67226
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0225-2025·2025-02-26
FDA Recalls Compounded Fentanyl Citrate IV Bags Due to Sterility Concerns
Fagron Compounding Services is recalling 1,330 units of fentanyl Citrate IV bags (Lot C274-000040409) distributed in Pennsylvania due to lack of sterility assurance. The product may pose a contamination risk if administered.
Product
fentaNYL Citrate In Sodium Chloride 1600mcg/100mL (16 mcg per mL) CII, Single use 100mL IV Bag, Fagron Sterile Services, 8710 E 34th St N, Wichita, KS 67726 Bar Code 71266-5060-01
Category
Drug
Distribution
1 state
HighFDA (Drugs)·D-0636-2024·2024-08-28
Lidocaine HCl Injection Recall Due to Lack of Sterility Assurance
Fagron Compounding Services is recalling Lidocaine HCl Injection due to lack of assurance of sterility. Four lot numbers distributed nationwide are affected with expiration date 10/14/2024.
Product
Lidocaine HCl Injection, 2% (20mg per mL) (100 mg per 5 mL) per syringe, Rx only, Fagron Sterile Services, 8710 E. 34th St, N. Wichita, KS 57226.
Category
Drug
Distribution
Distributed nationwide
ModerateFDA (Drugs)·D-0125-2024·2023-12-06
Compounded Ophthalmic Medication Bottles Mislabeled as Single-Use Syringes
Fagron Compounding Services is recalling 756 bottles of compounded ophthalmic medication because labels incorrectly identify the container as a 0.5mL single-use syringe instead of a 5mL dropper bottle. No adverse events have been reported.
Product
Tropicamide 1% (10mg/mL), Cyclopentolate 1% (10mg/mL), Phenylephrine 2.5% (25mg/mL), Ketorolac 0.5% (5mg/mL), 5 mL bottles, For Topical Ophthalmic Use Only, Not for IV Use, This is a Compounded Drug, Hospital & Office Use Only, Fagron Sterile Services, 8710 E 34th St N Wichita, K
Category
Drug
Distribution
Distributed nationwide